The level of prolactin in patient with CKD V stage, which are treated with hemodialysis
Journal Title: УКРАЇНСЬКИЙ ЖУРНАЛ НЕФРОЛОГІЇ ТА ДІАЛІЗУ - Year 2018, Vol 3, Issue 59
Abstract
The prevalence of hyperprolactinemia in patients treated with hemodialysis (HD) is 30-65%. Aim of our work was to investigate the prolactin (PL) level in patients treated with hemodialysis. Methods. An open prospective, non-randomized study it was involved 43 patients with CKD in the VD stage treated with hemodialysis. Criteria for inclusion of patients in the study were: informed consent of the patient to participate in the study, treatment of HD for more than three months, Kt / V> 1,2; vascular access - AV-fistula. The exclusion criteria were: refusal of the patient to participate in the study, liver cirrhosis, acute hepatitis B, C, hypothyroidism, acute coronary syndrome, stroke, pregnancy, patients with malignant neoplasms; those who systemically receive medications such as tricyclic antidepressants, monoamine oxidase inhibitors, reserpine, methyldopa, phenothiazine derivatives, antiemetic drugs (zocrama metoclopramide), dopamine synthesis inhibitors, and antipsychotics. All patients were evaluated for PL in serum. Results. Patients treated with HD have reported an elevated PL level in 32 (74%) patients. The level of serum PL in patients treated with HD was higher compared to the control group: 47.17 ± 32.4 versus 11.76 ± 4.33 ng/ml (p <0.001). The violation of the menstrual cycle was 85% in the group of women with elevated PL compared with 20% in women with normal PL (p <0,05). In groups of women and men with elevated PL level, the Hb level was significantly lower (p <0,05). It was established that the level of TL had a negative correlation with the level of Hb (r = -0,36; p = 0,02) and a positive correlation between the level of TL and CRP (r = 0,32; p = 0,03). Conclusions. The prevalence of hyperprolactinemia in our study was 74%. Violations of the menstrual cycle were significantly more common in women with hyperprolactinemia (85% vs. 20%). The increase in the concentration of PL has a negative correlation with the level of Hb and a positive correlation with the level of CRP, which suggests the involvement of PB in the processes of chronic inflammation
Authors and Affiliations
I. Dudar, V. Savchuk, O. Loboda, Yu. I. Gonchar
Keywords
Related Articles
- EP ID EP414697
- DOI 10.31450/ukrjnd.3(59).2018.06
- Views 68
- Downloads 0
Treatment of urinary tract infections in condition of growing antibiotic resistance: Antimicrobial Stewardship program
Resistance to common groups of antibiotics has been increasing in the treatment of urinary tract infections worldwide. In the United States, CDC has estimated that more thаn 2 million infections and 23,000 deaths are due...
Лептин сироватки як предиктор адекватності перитонеального діалізу: одноцентрове проспективне, поздовжнє дослідження
Гіперлептинемія часто спостерігається у пацієнтів, які лікуються методом перитонеального діалізу (ПД). Проте, дослідження щодо взаємозв'язку між рівнем лептину крові і виживанням методу ПД є поодинокими та суперечливими....
ПОРУШЕННЯ НУТРИЦІЙНОГО СТАТУСУ У ХВОРИХ, ЯКІ ЛІКУЮТЬСЯ ПЕРИТОНЕАЛЬНИМ ДІАЛІЗОМ
работа посвящена проблеме нарушения нутриционного статуса у больных, которые лечатся перитонеальным диализом, оговорены основные причины нарушений нутриционного статуса,также описана классификация белково- энергетической...
Pneumonia in patients with chronic kidney disease V D stage: pathogenetic aspects of complex therapy and outcomes
The aim of our study was to increase the effectiveness of treatment of comorbid pneumonia in patients with CKD VD stage. Materials and Methods. 73 patients with CKD VD st. (59 on HD and 14 on PD) with mild to moderate c...
ПРАКТИЧНА ЦІННІСТЬ ВИЗНАЧЕННЯ ПОКАЗНИКІВ ОКСИДАТИВНОГО СТРЕСУ У ХВОРИХ НАПІЄЛОНЕФРИТ
Робота присвячена практичному застосуванню показників оксидативного стресу в клінічній практиці та використання їх для моніторингу та оптимізаціїлікування хворих на пієлонефрит.